Trustworthy multimodal biosensing in cardiovascular health: integrating uncertainty, causality, and signal integrity for clinical reliability

Cardiovascular disease (CVD) monitoring increasingly relies on multimodal biosensors, including electrocardiography (ECG), photoplethysmography (PPG), and advanced imaging systems. While deep learning has enhanced the analytical capacity of these biosensors, the translation of multimodal sensing data into clinical practice is hindered by a trustworthiness gap. Current biosensing architectures often lack robustness to sensor noise, produce poorly calibrated confidence estimates, ignore physiological causality, and fail to align with clinician workflows. Employing a systematic narrative review methodology across PubMed, IEEE Xplore, Scopus, and arXiv (2018–2026), this paper synthesizes the literature around six interconnected challenge areas in biosensor data integration: uncertainty quantification and conflict resolution; handling missing and misaligned modalities; knowledge-guided representation and fusion; causal and evidential reasoning; robust clinical evaluation; and human-centered integration. We propose a taxonomy of fusion strategies based on their trustworthiness properties and identify critical limitations in current methodologies, such as the tendency of black-box transformers to exploit spurious correlations in sensor data and the brittleness of early fusion under distribution shift. Furthermore, we outline a comprehensive research roadmap emphasizing causal disentanglement, federated multimodal learning, and interactive clinician-AI loops. By bridging algorithmic innovation with biosensor reliability, this review provides a blueprint for developing reliable, interpretable, and equitable multimodal biosensing systems. However, we emphasize that while these technical directions are promising, prospective clinical validation, standardized regulatory benchmarks, and equitable dataset curation remain essential prerequisites before these systems can be considered clinically validated solutions capable of transforming cardiovascular care.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2026-11-17
DOI
https://doi.org/10.3389/fbioe.2026.1925414
Primary Topic
Non-Invasive Vital Sign Monitoring
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Trustworthy multimodal biosensing in cardiovascular health: integrating uncertainty, causality, and signal integrity for clinical reliability

Chen Zhong, Lanfang Lei, Muhammad Shehzad Khan, Qaisar Khan et al.
3 links
Frontiers in Bioengineering and Biotechnology
Non-Invasive Vital Sign Monitoring
article

Trustworthy multimodal biosensing in cardiovascular health: integrating uncertainty, causality, and signal integrity for clinical reliability

Chen Zhong, Lanfang Lei, Muhammad Shehzad Khan, Qaisar Khan, Adeel Akram, Wasim Ullah Khan, Derrick Boateng
article en

Abstract

Cardiovascular disease (CVD) monitoring increasingly relies on multimodal biosensors, including electrocardiography (ECG), photoplethysmography (PPG), and advanced imaging systems. While deep learning has enhanced the analytical capacity of these biosensors, the translation of multimodal sensing data into clinical practice is hindered by a trustworthiness gap. Current biosensing architectures often lack robustness to sensor noise, produce poorly calibrated confidence estimates, ignore physiological causality, and fail to align with clinician workflows. Employing a systematic narrative review methodology across PubMed, IEEE Xplore, Scopus, and arXiv (2018–2026), this paper synthesizes the literature around six interconnected challenge areas in biosensor data integration: uncertainty quantification and conflict resolution; handling missing and misaligned modalities; knowledge-guided representation and fusion; causal and evidential reasoning; robust clinical evaluation; and human-centered integration. We propose a taxonomy of fusion strategies based on their trustworthiness properties and identify critical limitations in current methodologies, such as the tendency of black-box transformers to exploit spurious correlations in sensor data and the brittleness of early fusion under distribution shift. Furthermore, we outline a comprehensive research roadmap emphasizing causal disentanglement, federated multimodal learning, and interactive clinician-AI loops. By bridging algorithmic innovation with biosensor reliability, this review provides a blueprint for developing reliable, interpretable, and equitable multimodal biosensing systems. However, we emphasize that while these technical directions are promising, prospective clinical validation, standardized regulatory benchmarks, and equitable dataset curation remain essential prerequisites before these systems can be considered clinically validated solutions capable of transforming cardiovascular care.

Frontiers in Bioengineering and BiotechnologyVol. 14
Department of Health (CN), City University of Hong Kong (HK), Yangtze University (CN), Donghua University (CN), Nanfang Hospital (CN), Yango University (CN), Nanfang College Guangzhou (CN)
Good health and well-being
Non-Invasive Vital Sign Monitoring
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon